159 related articles for article (PubMed ID: 2893388)
1. D1 and D2 dopamine binding site up-regulation and apomorphine-induced stereotypy.
Chipkin RE; McQuade RD; Iorio LC
Pharmacol Biochem Behav; 1987 Dec; 28(4):477-82. PubMed ID: 2893388
[TBL] [Abstract][Full Text] [Related]
2. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density.
LaHoste GJ; Marshall JF
Synapse; 1992 Sep; 12(1):14-26. PubMed ID: 1357762
[TBL] [Abstract][Full Text] [Related]
3. Similarity of clozapine and SCH 23390 in reserpinized rats suggests a common mechanism of action.
Chipkin RE; Latranyi MB
Eur J Pharmacol; 1987 Apr; 136(3):371-5. PubMed ID: 2886345
[TBL] [Abstract][Full Text] [Related]
4. Changes in apomorphine-induced stereotypy as a result of subacute neuroleptic treatment correlates with increased D-2 receptors, but not with increases in D-1 receptors.
Fleminger S; Rupniak NM; Hall MD; Jenner P; Marsden CD
Biochem Pharmacol; 1983 Oct; 32(19):2921-7. PubMed ID: 6138043
[TBL] [Abstract][Full Text] [Related]
5. Rapidly induced dopaminergic supersensitivity: D1/D2 receptor participation and its prevention by an MAO-inhibitor.
Kleinman A; Tieppo CA; Florez GM; Felicio LF; Nasello AG
Pharmacol Biochem Behav; 2006 Nov; 85(3):592-600. PubMed ID: 17157367
[TBL] [Abstract][Full Text] [Related]
6. D1 and D2 dopamine receptor-mediated mechanisms and behavioral supersensitivity.
Marin C; Parashos SA; Kapitzoglou-Logothetis V; Peppe A; Chase TN
Pharmacol Biochem Behav; 1993 May; 45(1):195-200. PubMed ID: 8516358
[TBL] [Abstract][Full Text] [Related]
7. Scopolamine modulates apomorphine-induced behavior in rats treated with haloperidol or SCH 23390.
Butkerait P; Friedman E
Eur J Pharmacol; 1988 Mar; 148(2):269-72. PubMed ID: 2897925
[TBL] [Abstract][Full Text] [Related]
8. Behavioral and biochemical expression of D1-receptor supersensitivity following SCH 23390 repeated administrations.
Gandolfi O; Roncada P; Dall'Olio R; Montanaro N
Brain Res; 1988 Jul; 455(2):390-3. PubMed ID: 2969768
[TBL] [Abstract][Full Text] [Related]
9. Effects of buspirone on dopamine dependent behaviours in rats.
Dhavalshankh AG; Jadhav SA; Gaikwad RV; Gaonkar RK; Thorat VM; Balsara JJ
Indian J Physiol Pharmacol; 2007; 51(4):375-86. PubMed ID: 18476392
[TBL] [Abstract][Full Text] [Related]
10. Behavioural stimulation is induced by separate dopamine D-1 and D-2 receptor sites in reserpine-pretreated but not in normal rats.
Arnt J
Eur J Pharmacol; 1985 Jul; 113(1):79-88. PubMed ID: 2931283
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological profile of SCH39166: a dopamine D1 selective benzonaphthazepine with potential antipsychotic activity.
Chipkin RE; Iorio LC; Coffin VL; McQuade RD; Berger JG; Barnett A
J Pharmacol Exp Ther; 1988 Dec; 247(3):1093-102. PubMed ID: 2905002
[TBL] [Abstract][Full Text] [Related]
12. Effects of D1 and D2 antagonists on basal and apomorphine decreased body temperature in mice and rats.
Chipkin RE
Pharmacol Biochem Behav; 1988 Jul; 30(3):683-6. PubMed ID: 2974995
[TBL] [Abstract][Full Text] [Related]
13. Positive and negative interactions in the behavioural expression of D1 and D2 receptor stimulation in a model of Parkinsonism: role of priming.
Morelli M; Fenu S; Cozzolino A; Di Chiara G
Neuroscience; 1991; 42(1):41-8. PubMed ID: 1830642
[TBL] [Abstract][Full Text] [Related]
14. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
Hu XT; White FJ
Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
[TBL] [Abstract][Full Text] [Related]
15. SCH 23390 may alter dopamine-mediated motor behaviour via striatal D-1 receptors.
Boyce S; Kelly E; Davis A; Fleminger S; Jenner P; Marsden CD
Biochem Pharmacol; 1985 May; 34(10):1665-9. PubMed ID: 2988552
[TBL] [Abstract][Full Text] [Related]
16. Correlated asymmetries in striatal D1 and D2 binding: relationship to apomorphine-induced rotation.
Glick SD; Lyon RA; Hinds PA; Sowek C; Titeler M
Brain Res; 1988 Jul; 455(1):43-8. PubMed ID: 2970881
[TBL] [Abstract][Full Text] [Related]
17. Evidence that the stimulus properties of apomorphine are mediated by both D1 and D2 receptor activation.
Schechter MD; Greer NL
Life Sci; 1987 Jun; 40(25):2461-71. PubMed ID: 2953944
[TBL] [Abstract][Full Text] [Related]
18. The dopamine autoreceptor agonist B-HT 920 stimulates denervated postsynaptic brain dopamine receptors in rodent and primate models of Parkinson's disease: a novel approach to treatment.
Hinzen D; Hornykiewicz O; Kobinger W; Pichler L; Pifl C; Schingnitz G
Eur J Pharmacol; 1986 Nov; 131(1):75-86. PubMed ID: 3816949
[TBL] [Abstract][Full Text] [Related]
19. Ontogeny of apomorphine-induced stereotypy and its D1 and D2 receptor mediation in rats depleted of dopamine as neonates.
Abrams DR; Bruno JP
Dev Psychobiol; 1992 Nov; 25(7):475-95. PubMed ID: 1459343
[TBL] [Abstract][Full Text] [Related]
20. Chronic ascorbate potentiates the effects of chronic haloperidol on behavioral supersensitivity but not D2 dopamine receptor binding.
Pierce RC; Rowlett JK; Bardo MT; Rebec GV
Neuroscience; 1991; 45(2):373-8. PubMed ID: 1762684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
